Residents or patients with incontinence are at risk, but those with mixed incontinence are the most vulnerable — especially when stools are liquid or diarrhea is present.3
In 2014, 3M brought together 20 international experts to look at gaps in IAD clinical care and to advance best practice principles that address those gaps. What will you find in their best practice principles document?
Hands-on clinicians will find practical guidance for.
Assessing risk
Preventing symptoms
Managing IAD
3M™ Cavilon™ Skin Care Solutions – including our new, innovative 3M™ Cavilon™ Advanced Skin Protectant – provide all the products you need for prevention and management of skin damage, even in the case of category 2 (moderate to severe) IAD.
is our revolutionary breakthrough barrier that protects patient skin for up to seven days.
creates a durable, breathable barrier — without zinc oxide or petrolatum.
Discover what makes 3M™ Cavilon™ Advanced Skin Protectant powerful enough to end IAD.
3M℠ Health Care Academy offers proven, practical online educational content to healthcare professionals. Explore available courses focused on IAD and other conditions.
Manage your training, test your knowledge, and receive certifications for completed courses.
1. Nix D, Haugen V (2010) Prevention and management of Incontinence-Associated Dermatitis. Drugs Aging 27(6); 491-6. 2. Gray M, Bartos S. Incontinence-Associated Dermatitis in the Acute Care Setting: A Prospective Multi-Site Epidemiological Study. Presented at the Symposium on Advanced Wound Care. May 2013. 3. Beekman D et al. Proceedings of the Global IAD Expert Panel. Incontinence-Associated Dermatitis: moving prevention forward. Best Practice Principles. Wound International 2015.